Drug
Beam 101
Beam 101: highest development phase Phase 1/2, developed by Beam Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Beam Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| BEAM-101 NCT05456880 | Phase 1/2 | Sickle Cell Disease |
Latest
No recent events.
Follow Beam 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.